BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8513124)

  • 1. Neuroactive peptides exist in the midbrain dopaminergic neurons that contain calbindin-D28k.
    German DC; Liang CL
    Neuroreport; 1993 May; 4(5):491-4. PubMed ID: 8513124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28K and calretinin.
    Liang CL; Sinton CM; German DC
    Neuroscience; 1996 Nov; 75(2):523-33. PubMed ID: 8931015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dopamine transporter mRNA levels in midbrain regions containing calbindin.
    Sanghera MK; Manaye KF; Liang CL; Lacopino AM; Bannon MJ; German DC
    Neuroreport; 1994 Aug; 5(13):1641-4. PubMed ID: 7819538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sparing of the dopaminergic neurons containing calbindin-D28k and of the dopaminergic mesocortical projections in weaver mutant mice.
    Gaspar P; Ben Jelloun N; Febvret A
    Neuroscience; 1994 Jul; 61(2):293-305. PubMed ID: 7969910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration.
    Liang CL; Sinton CM; Sonsalla PK; German DC
    Neurodegeneration; 1996 Dec; 5(4):313-8. PubMed ID: 9117542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vulnerability of midbrain dopaminergic neurons in calbindin-D28k-deficient mice: lack of evidence for a neuroprotective role of endogenous calbindin in MPTP-treated and weaver mice.
    Airaksinen MS; Thoenen H; Meyer M
    Eur J Neurosci; 1997 Jan; 9(1):120-7. PubMed ID: 9042576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calbindin-D28k-containing neurons in the human hypothalamus: relationship to dopaminergic neurons.
    Sanghera MK; Zamora JL; German DC
    Neurodegeneration; 1995 Dec; 4(4):375-81. PubMed ID: 8846230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells.
    German DC; Manaye KF; Sonsalla PK; Brooks BA
    Ann N Y Acad Sci; 1992 May; 648():42-62. PubMed ID: 1353337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans.
    McRitchie DA; Hardman CD; Halliday GM
    J Comp Neurol; 1996 Jan; 364(1):121-50. PubMed ID: 8789281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calbindin D-28K in the dopaminergic mesocortical projection of a monkey (Aotus trivirgatus).
    Gaspar P; Heizmann CW; Kaas JH
    Brain Res; 1993 Feb; 603(1):166-72. PubMed ID: 8095839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical characterization of neuron-rich rat brain primary cultures: calbindin D28K as marker of a neuronal subpopulation.
    Pfeiffer B; Norman AW; Hamprecht B
    Brain Res; 1989 Jan; 476(1):120-8. PubMed ID: 2914206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration.
    McCormack AL; Atienza JG; Langston JW; Di Monte DA
    Neuroscience; 2006 Aug; 141(2):929-937. PubMed ID: 16677770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calbindin-D28k in nerve cell nuclei.
    German DC; Ng MC; Liang CL; McMahon A; Iacopino AM
    Neuroscience; 1997 Dec; 81(3):735-43. PubMed ID: 9316025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calretinin and calbindin-D28k in dopaminergic neurons of the rat midbrain: a triple-labeling immunohistochemical study.
    Nemoto C; Hida T; Arai R
    Brain Res; 1999 Oct; 846(1):129-36. PubMed ID: 10536220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine transporter mRNA levels are high in midbrain neurons vulnerable to MPTP.
    Sanghera MK; Manaye K; McMahon A; Sonsalla PK; German DC
    Neuroreport; 1997 Oct; 8(15):3327-31. PubMed ID: 9351666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calbindin-D28k immunoreactive neurons form two populations in the rat nucleus accumbens: a compartmental study.
    Hussain Z; Totterdell S
    Brain Res; 1994 Sep; 656(1):191-8. PubMed ID: 7804837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous Ca2+ buffer concentration and Ca2+ microdomains in hippocampal neurons.
    Müller A; Kukley M; Stausberg P; Beck H; Müller W; Dietrich D
    J Neurosci; 2005 Jan; 25(3):558-65. PubMed ID: 15659591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calbindin controls release probability in ventral tegmental area dopamine neurons.
    Pan PY; Ryan TA
    Nat Neurosci; 2012 Jun; 15(6):813-5. PubMed ID: 22544312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys.
    Lavoie B; Parent A
    Neuroreport; 1991 Oct; 2(10):601-4. PubMed ID: 1684519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calbindin-D28K and the peptidergic neuroendocrine system in rat gut: an immunohistochemical study.
    Resibois A; Vienne G; Pochet R
    Biol Cell; 1988; 63(1):67-75. PubMed ID: 2461241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.